Skip to main content
Caplight Logo









PaMeLa, Inc.

PaMeLa, Inc.

Private
ToyonakaHealthcare & Life Scienceshttps://pain-ml.com/

Last Round

Series B

Oct 1, 2021

Est. Valuation

$12.34M

Total Funding Raised

$4.56M

Company Overview

PaMeLa, Inc. is a healthcare technology company that develops EEG-based AI systems to objectively quantify and visualize pain levels for medical diagnosis and pharmaceutical research.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

pain assessmentmedical deviceelectroencephalographyEEGpain techdigital healthmedical AIclinical researchobjective pain measurementhealth IoTpain quantificationdrug developmentdiagnostic accuracymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PaMeLa, Inc. Comparables

Compare PaMeLa, Inc. with similar companies based on industry and business-model similarity.

PaMeLa, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medasense Biometrics
81%
BioTraceIT
81%
MedStorm Innovation
78%

PaMeLa, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 1, 2021
StrategicDec 31, 2019
Series AApr 30, 2019

PaMeLa, Inc. Investors

Notable investors and investment history

PaMeLa, Inc. investors
InvestorRounds
MedVenture PartnersSeries A
NEC Capital SolutionsSeries B
Osaka University Venture Capital Co., Ltd.Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2021

    $4.56M round with Dai-ichi Life Insurance and NEC Capital Solutions.

  • Dec 31, 2019

    Teikoku Seiyaku Co., Ltd. participated in the strategic round.

PaMeLa, Inc. Filings

Explore SEC and related filing metadata, where available.

PaMeLa, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PaMeLa, Inc.'s valuation, stock price, and market status.

Is PaMeLa, Inc. a public or private company?

PaMeLa, Inc. is a private company.

What is the current stock price of PaMeLa, Inc.?

PaMeLa, Inc. is a private company with no public stock price. Caplight tracks PaMeLa, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is PaMeLa, Inc. worth (valuation)?

PaMeLa, Inc.'s valuation is estimated at $12.3M based on funding round data.

Can I buy PaMeLa, Inc. stock?

PaMeLa, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PaMeLa, Inc.'s last funding round?

PaMeLa, Inc.'s most recent funding round was Series B on October 1, 2021.

Who are the main investors in PaMeLa, Inc.?

Key investors in PaMeLa, Inc. include MedVenture Partners, NEC Capital Solutions, Osaka University Venture Capital Co., Ltd..

Will PaMeLa, Inc. IPO soon?

No public IPO plans have been announced for PaMeLa, Inc..

How can I track PaMeLa, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PaMeLa, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersToyonaka
Year Founded2016
Last FundingOct 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?